Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Technologies Highlights Advances in Precision Oncology at the 60th Annual Meeting of the American Society of Hematology
40+ Abstracts Highlight the Value of the nCounter Platform in Hematology & Immuno-oncology, Including Thirteen that Demonstrate the Potential Utility of the LymphMark Lymphoma Subtyping Test SEATTLE , Nov. 29, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString to Present at the Evercore ISI HEALTHCONx Conference
SEATTLE , Nov. 20, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 Evercore ISI HEALTHCONx
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for Third Quarter of 2018
SEATTLE , Nov. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter of 2018. Third Quarter Financial Highlights Total product
View HTML
Toggle Summary NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing
SEATTLE , Nov. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a new gene expression panel for the molecular characterization of CAR-T cells in
View HTML
Toggle Summary NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Includes Data from More than Twenty-Five Studies, Including Six Using GeoMx Digital Spatial Profiler SEATTLE , Nov. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today
View HTML
Toggle Summary NanoString to Present at the 2018 Canaccord Medical Technologies and Diagnostics Forum
SEATTLE , Nov. 05, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 Canaccord Medical Technologies
View HTML
Toggle Summary NanoString Highlights Advances in Product Pipeline and Application Development at the 2018 Association of Molecular Pathology Conference
Demonstrates Potential of Hyb & Seq NGS Platform for Infectious Disease Applications SEATTLE , Oct. 30, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today highlighted advances in
View HTML
Toggle Summary MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology
Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE , Oct. 29, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products,
View HTML
Toggle Summary NanoString Announces $100 Million Term Loan Facility with CRG
SEATTLE , Oct. 15, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a new $100 million term loan facility with the CR Group L.P.
View HTML
Toggle Summary Landmark Publications in Nature Medicine use NanoString’s Digital Spatial Profiling Platform to Discover Novel Insights in Immuno-Oncology
Two Independent Studies Use the GeoMx Digital Spatial Profiler to Investigate the Role of the Tumor and Micro-environment in Immunotherapy Response SEATTLE , Oct. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research
View HTML